国药现代
(600420)
| 流通市值：157.19亿 | | | 总市值：157.19亿 |
| 流通股本：13.41亿 | | | 总股本：13.41亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 8,593,322,350.59 | 5,960,093,922.86 | 3,123,407,807.27 | 12,069,930,213.38 |
| 营业收入 | 8,593,322,350.59 | 5,960,093,922.86 | 3,123,407,807.27 | 12,069,930,213.38 |
| 二、营业总成本 | 7,149,548,193.4 | 4,938,858,986.31 | 2,626,556,816.56 | 10,999,674,408.49 |
| 营业成本 | 5,182,776,783.47 | 3,598,033,483.09 | 1,849,867,447.49 | 7,444,013,143.5 |
| 税金及附加 | 91,849,830.17 | 67,551,190.03 | 38,402,592.27 | 138,119,869.62 |
| 销售费用 | 969,120,997.86 | 716,477,575.38 | 453,603,798.38 | 2,153,535,875.44 |
| 管理费用 | 556,786,615.94 | 373,755,281.67 | 184,147,588.34 | 770,065,790.3 |
| 研发费用 | 416,208,957.38 | 244,601,026.49 | 121,609,766.63 | 569,431,845.96 |
| 财务费用 | -67,194,991.42 | -61,559,570.35 | -21,074,376.55 | -75,492,116.33 |
| 其中:利息费用 | 27,837,847.97 | 18,697,936.94 | 9,474,971.45 | 57,883,690.44 |
| 其中:利息收入 | 74,174,042.98 | 54,380,605.68 | 22,839,464.12 | 109,024,761.94 |
| 加:投资收益 | 36,495,743.56 | 16,838,682.09 | 2,479,299.44 | 27,453,725.69 |
| 资产处置收益 | -5,493,372.69 | -2,049,581.83 | -2,197,538.39 | -31,845,024.31 |
| 资产减值损失(新) | -93,834,179.46 | -11,308,517.94 | -3,251,252.97 | -79,105,481.47 |
| 信用减值损失(新) | -4,009,663.05 | -3,597,539.2 | -2,755,504.8 | 18,054,730.86 |
| 其他收益 | 91,439,320.66 | 75,586,044.01 | 33,474,373.62 | 76,813,337.26 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 1,468,372,006.21 | 1,096,704,023.68 | 524,600,367.61 | 1,081,627,092.92 |
| 加:营业外收入 | 10,042,756.13 | 7,749,451.45 | 802,847.15 | 25,490,717.38 |
| 减:营业外支出 | 21,724,505.36 | 18,051,572.89 | 17,399,920.23 | 10,558,245.8 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 1,456,690,256.98 | 1,086,401,902.24 | 508,003,294.53 | 1,096,559,564.5 |
| 减:所得税费用 | 257,243,613.37 | 199,514,176.61 | 82,145,022.39 | 131,948,830.32 |
| 六、净利润 | 1,199,446,643.61 | 886,887,725.63 | 425,858,272.14 | 964,610,734.18 |
| 持续经营净利润 | 1,199,446,643.61 | 886,887,725.63 | 425,858,272.14 | 964,610,734.18 |
| 归属于母公司股东的净利润 | 954,526,387.18 | 718,477,263.45 | 331,257,150.18 | 691,880,495.68 |
| 少数股东损益 | 244,920,256.43 | 168,410,462.18 | 94,601,121.96 | 272,730,238.5 |
| (一)基本每股收益 | 0.71 | 0.54 | 0.25 | 0.54 |
| (二)稀释每股收益 | 0.71 | 0.54 | 0.25 | 0.54 |
| 八、其他综合收益 | -111,674.09 | -111,674.09 | - | 90,798.02 |
| 归属于母公司股东的其他综合收益 | -111,674.09 | -111,674.09 | - | 90,798.02 |
| 九、综合收益总额 | 1,199,334,969.52 | 886,776,051.54 | 425,858,272.14 | 964,701,532.2 |
| 归属于母公司股东的综合收益总额 | 954,414,713.09 | 718,365,589.36 | 331,257,150.18 | 691,971,293.7 |
| 归属于少数股东的综合收益总额 | 244,920,256.43 | 168,410,462.18 | 94,601,121.96 | 272,730,238.5 |
| 公告日期 | 2024-10-29 | 2024-08-28 | 2024-04-30 | 2024-03-30 |
| 审计意见(境内) | | | | 标准无保留意见 |